NCT07125378 Living Independence Through Functional Training
| NCT ID | NCT07125378 |
| Status | Recruiting |
| Phase | Phase 1, Phase 2 |
| Sponsor | University of Florida |
| Condition | Mobility Limitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-01-06 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 10 participants in total. It began in 2026-01-06 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the research is to evaluate the feasibility and benefits of a six-week hybrid task-oriented resistance exercise program for older adults who have been recently discharged from home health care.
Eligibility Criteria
Inclusion Criteria: * between the ages of 65 and 90 years * community-dwelling * live within a 50-mile radius of the study site with wireless connectivity in the area * mobility limitations as indicated by self-reported of using a mobility aid or having unsteady gait or walking slower than before * cognitive decline as indicated by a score \< 12 on Mini MoCA Version 2.1 * a care partner or adult family member living in the home or nearby * willing to wear an activity tracker during the study period Exclusion Criteria: * plan to receive skilled rehabilitation services * plan to move away outside the study area in two months * reside in an assisted living or long-term care facility or plan to relocate to such a facility in the next three months * severe vision or hearing loss that impedes activity performance or communication * unable to stand or walk even with a mobility aid * unable to follow a one-step command or carry on a conversation over the phone * unable to commit to the six-week exercise program * contradictions to resistance exercise, such as the end-stage heart failure * a terminal disease or on hospice care * a neurological condition affecting motor skills * not able to provide consent.
Contact & Investigator
Chiung-ju Liu Associate Professor, phD
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT07125378 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Mobility Limitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07125378 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07125378 currently recruiting?
Yes, NCT07125378 is actively recruiting participants. Contact the research team at c.liu1@phhp.ufl.edu for enrollment information.
Where is the NCT07125378 trial being conducted?
This trial is being conducted at Gainesville, United States, Gainesville, United States.
Who is sponsoring the NCT07125378 clinical trial?
NCT07125378 is sponsored by University of Florida. The principal investigator is Chiung-ju Liu Associate Professor, phD at University of Florida. The trial plans to enroll 10 participants.